About 100 reports

Pulmonary Arterial Hypertension (Cardiovascular) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Drugs In Development, 2021, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline...

  • Drug Development
  • Hypertension
  • South Africa
  • Drug Approval
  • Pharmaceutical Registrations

China’s demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption...

  • Hypertension
  • China
  • Industrial Production
  • Labour Force

Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class, By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ subcutaneous, Inhalational), By Region, And Segment Forecasts, 2022 - 2030 Pulmonary Arterial Hypertension Market Growth & Trends The...

  • Hypertension
  • World
  • APAC
  • North America
  • United States

Pulmonary Arterial Hypertension - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H2 2020, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary...

  • Hypertension
  • World
  • United States
  • North America
  • Drug Approval
  • Pharmaceutical Registrations

Pulmonary Arterial Hypertension market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Pulmonary Arterial Hypertension Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Pulmonary Arterial Hypertension types,...

  • Hypertension
  • World

Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Drugs In Development, 2021, provides an overview of the Hypertension (Cardiovascular) pipeline landscape. Hypertension, also referred to as high...

  • Hypertension
  • Cardiology
  • World

The global pulmonary arterial hypertension (PAH) drugs market reached a value of US$ 6.8 Billion in 2020. Looking forward, the analyst expects the market to grow at a CAGR of 7.3% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...

  • Hypertension
  • World
  • Medical Technology Density

Pulmonary Arterial Hypertension Market Report Overview Pulmonary Arterial Hypertension market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Pulmonary Arterial Hypertension market types and applications. It is a focused study on Pulmonary...

  • Hypertension
  • World
  • Health Provider Density

Abstract: - Global Pulmonary Hypertension Market to Reach $4.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Pulmonary Hypertension estimated at US$3.5 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 2.8% over the analysis period 2020-2027....

  • Hypertension
  • World
  • China
  • United States

Pulmonary Arterial Hypertension Market Size, Share & Trends Analysis Report By Drug Class (Prostacyclin And Prostacyclin Analogs, SGC Stimulators, ERA, PDE-5), By Region, And Segment Forecasts, 2021 - 2028 Pulmonary Arterial Hypertension Market Growth & Trends The global pulmonary arterial...

  • Therapy
  • Hypertension
  • In Vitro Diagnostic Reagent
  • World
  • APAC
  • Tobacco Consumption

Pulmonary Arterial Hypertension - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pulmonary Arterial Hypertension - Pipeline Review, H1 2020, provides an overview of the Pulmonary Arterial Hypertension (Cardiovascular) pipeline landscape. Pulmonary...

  • Hypertension
  • South Africa
  • Drug Approval
  • Cause-Specific Mortality Rate

Pulmonary Arterial Hypertension Market Value forecast, New Business Opportunities and Companies: Outlook By Type, Application, By End User and By Country, 2020- 2026 The study predicts the short term and long term trends that can shape up the future of the Pulmonary Arterial Hypertension market including the COVID-19...

  • Hypertension
  • APAC
  • Central America

Pulmonary Arterial Hypertension - Epidemiology Forecast to 2029 Summary Pulmonary arterial hypertension (PAH) is a rare, progressive disorder characterized by vascular proliferation and remodeling of the small pulmonary arteries (Humbert et al., 2004; Humbert et al., 2010; Simonneau et al., 2004)....

  • Hypertension
  • World
  • Mortality Rate
  • Sex Ratio

Hypertension - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Pipeline Review, H1 2020, provides an overview of the Hypertension (Cardiovascular) pipeline landscape. Hypertension, also referred to as high blood pressure,...

  • Hypertension
  • Cardiology
  • World

Idiopathic (Essential) Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Idiopathic (Essential) Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Idiopathic (Essential) Hypertension pipeline landscape. The report provides comprehensive...

  • Hypertension
  • Cardiology
  • Therapy
  • Research And Development
  • World

Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Pulmonary Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Hypertension
  • Cardiology
  • Therapy
  • Research And Development
  • World

Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Chronic Thromboembolic Pulmonary Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Chronic Thromboembolic Pulmonary Hypertension pipeline landscape. The...

  • Hypertension
  • Cardiology
  • Therapy
  • Research And Development
  • World

Resistant Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Resistant Hypertension (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Resistant Hypertension pipeline landscape. The report provides comprehensive information on the therapeutics under development...

  • Hypertension
  • Cardiology
  • Therapy
  • Research And Development
  • World

Acromegaly and Gigantism - Epidemiology Forecast to 2029 Summary Acromegaly and gigantism are rare disorders of the pituitary gland, characterized by the hypersecretion of growth hormone (GH).In 98% of the cases of acromegaly and gigantism, the hypersecretion of GH results from a benign GH- secreting...

  • Cardiovascular Disease
  • Diabetes
  • Epidemiology
  • Hypertension
  • World
  • Diabetes Prevalence
  • Prescription Drug Sales

Telmisartan Market by Indication (Hypertension and Cardiovascular Risk Reduction) and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2020–2027 The global telmisartan market was valued at $3,453 million in 2019,...

  • Generic Drug
  • Pharmacy
  • Hypertension
  • In-Store Retail
  • Cardiology
  • World
  • APAC

Vascular Disease Devices Market by Product (Stents, Balloons, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Others), and End User (Hospitals and Cardiac Centers, and Ambulatory Surgical Center): Global Opportunity Analysis and Industry Forecast, 2021––2030 The global vascular...

  • Cardiovascular Disease
  • Cardiovascular Devices
  • Hypertension
  • Compression Therapy
  • Implantable Delivery
  • Cardiology
  • World
  • APAC

The global prevalence of CKD is estimated to be about 9% to 10%.Chronic Kidney Disease (CKD) is associated with poor outcomes, mainly due to the high burden of comorbidity. Along with rising aging population, increasing number of CKD patients are suffering from comorbidities such as hypertension, diabetes, heart failure, cancer, and...

  • Chronic Disease
  • Renal Disease
  • Managed Care
  • Antidiabetics
  • Heart Failure
  • Hypertension
  • World

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Hypertension
  • World
  • Europe
  • China
  • United States

Report Highlights:   - The global nutraceutical market should grow from $289.8 billion in 2021 to $438.9 billion by 2026, at compound annual growth rate (CAGR) of 8.7% for the period of 2021-2026. - The global market for weight loss products and services should grow from $254.9 billion in 2021 to reach $377.3...

  • Cardiovascular Disease
  • Public Health
  • Nutraceutical
  • Hypertension
  • World
  • Life Expectancy

KEY FINDINGS During the forecast period from 2019 to 2028, the global antihypertensive drugs market is estimated to grow with a CAGR of 3.21%. A surge in the prevalence of hypertension and a rise in awareness of complications related to hypertension, as well as an increase in the geriatric population and sedentary lifestyle,...

  • Hypertension
  • Antihypertensive
  • World
  • North America

The Global Intra-Abdominal Pressure Measurement Devices Market size is expected to reach $175.1 Million by 2026, rising at a market growth of 11.1% CAGR during the forecast period. Intra-abdominal pressure (IAP) is the steady-state pressure contained inside the abdominal cavity. Intra-abdominal pressure measurement devices (IPMDs) are used...

  • Intensive Care
  • Hypertension
  • World
  • APAC
  • Asia
  • Europe
  • North America
  • Latin America
  • Chronic Disease Prevalence

Hypertension - Pipeline Review, H2 2019 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Hypertension - Pipeline Review, H2 2019, provides an overview of the Hypertension (Cardiovascular) pipeline landscape. Hypertension, also referred to as high blood pressure,...

  • Hypertension
  • Cardiology
  • World

The global renal denervation systems market exhibited strong growth during 2015-2020. Looking forward, the analyst expects the market to grow at a CAGR of 37.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of...

  • Hypertension
  • Research And Development
  • World

Calcitonin Gene Related Peptide Type 1 Receptor - Drugs In Development, 2021 Summary Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) pipeline Target constitutes close to 8 molecules. The latest report Calcitonin Gene Related Peptide Type 1 Receptor -...

  • Pharmaceutical
  • Hypertension
  • World
  • Medicine Use
  • Pharmaceutical Registrations

Global Blood Pressure Transducers Market 2021-2025 The analyst has been monitoring the blood pressure transducers market and it is poised to grow by $ 113.67 mn during 2021-2025, progressing at a CAGR of over 5% during the forecast period. Our report on blood pressure transducers market provides a holistic analysis, market...

  • Hypertension
  • Specialty Hospital
  • Marketing Research
  • Managed Care
  • World